Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 136,844 shares at $12.72 ($1.7M) on 2021-02-09, disclosed to the SEC on 2021-02-11.
Open-market sale of $1.7M TEVA by Executive VP, European Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.72 | 13,135 | $167K | 9.6% |
| 2 | $12.72 | 13,135 | $167K | 9.6% |
| 3 | $12.72 | 55,287 | $703K | 40.4% |
| 4 | $12.72 | 55,287 | $703K | 40.4% |
| Total | $12.72 avg | 136,844 | $1.7M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |